Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets. Position Overview We are seeking a Senior Director/Director to lead the R&D Finance function, which serves as the primary finance business partner to R&D leadership within our Finance organization. The role oversees a hybrid finance and accounting team responsible for accruals, internal reporting, budgeting and forecasting, and strategic financial support across our Research, Technical Operations, and Development organizations. This is a high-impact leadership role that combines a strong understanding of US GAAP accounting with forward-looking FP&A capabilities and a strategic mindset to drive financial performance management and decision support across R&D. The role will partner closely with Finance leadership, including the Controller and the Director of FP&A and Commercial Finance, as well as with leaders across the R&D organization. The role will be expected to build and scale the R&D Finance team as Immunome’s pipeline grows and matures.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
101-250 employees